Scientific Sessions
Scientific Sessions
  • Program
  • #AHA24
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Journeys
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Journeys
Resources
  • Program
  • #AHA24
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon Facebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
Nov 12th, 2020

Session to explore COVID-19’s disproportionate burden on people of color

Panelists will discuss interventions intended to reduce disparities in health care, with a focus on community-based participatory research.


Getty Images 1222832010

A session at 9 a.m. Friday will discuss how the COVID-19 pandemic has underscored myriad problems in the U.S. health care system, including how social determinates affect health, health care and outcomes.


Melissa S. Burroughs, MD, MS, FAAC

“The social determinants of health, including income, education, housing, culture and language, are largely responsible for the disproportionate burden of COVID-related morbidity that communities of color face,” said Melissa S. Burroughs, MD, MS, FAAC, a panelist on “How to Use Behavioral Interventions to Advance Equity in Cardiovascular Health.”

“Additionally, cardiovascular disease risk factors, such as obesity, Type 2 diabetes and hypertension are more prevalent in African Americans and Hispanics/Latinos. These risk factors can increase the risk of the complications from severe COVID-19 infection and mortality.”

Paired with disparities related to access to care, communities of color will likely have a harder time getting COVID-19 treatments and vaccines when available, said Dr. Burroughs, a general cardiologist at Stanford Health Care in Emeryville, California.

“We must remain vigilant that equitable access to care is available to all communities,” she said.

Health inequities go beyond COVID-19, she said. “African Americans and Hispanics/Latinos with heart failure often face multiple barriers to care, particularly when faced with end-stage disease that requires advanced therapies such as transplant and ventricular assist devices.”

The session’s panelists will discuss several different types of interventions to reduce disparities in health care — particularly community-based participatory research.

“Community-based participatory research is not a new methodology, but we are seeing the methodology applied to address risk factors for cardiovascular disease, including hypertension, diet and exercise,” Dr. Burroughs said . “These interventions can be based in churches and other community organizations. The objective is to bridge the gap between the medical office and the communities that physicians and health care organizations serve.”

Digital health interventions are promising as well, although Burroughs noted that they are not one-size-fits-all and must be adapted to better address needs of diverse patients.

Interesting Stories
Unmet Needs in Hypertension Toolkit
Sponsored by Medtronic
Unmet Needs in Hypertension Toolkit
Screening for Kidney Disease to Reduce CVD Risk
Sponsored by Bayer
Screening for Kidney Disease to Reduce CVD Risk
Lp(a) and Peripheral Artery Disease Toolkit
Sponsored by Kaneka Corporation
Lp(a) and Peripheral Artery Disease Toolkit
CME Gameshow Style Sympo: Navigating New Paradigms in Thrombosis Management
Sponsored by Medscape
CME Gameshow Style Sympo: Navigating New Paradigms in Thrombosis Management
More Content
Health Tech winners
AHA24
AI medical company wins global health tech competition at #AHA24
Nov 20th, 2024
241116 American Heart Association Keynote 0080
AHA24
LBS 08: Advances in lipid therapeutics
Nov 20th, 2024
Crowd shot
AHA24
LBS 07: New approaches to managing AFib
Nov 20th, 2024
Stage shot
AHA24
LBS 06: Medical therapy for heart failure
Nov 20th, 2024
Stage shot
AHA24
LBS 05: Innovation in prevention
Nov 20th, 2024
French Quarter balcony shot
AHA24
Save the date for #AHA25 in New Orleans
Nov 20th, 2024
Asgar headshot
AHA24
Managing patients with symptomatic mitral or tricuspid regurgitation
Nov 18th, 2024
Nancy Brown headshot
AHA24
AHA CEO: Driving breakthroughs
Nov 18th, 2024
Shot of speakers
AHA24
Environmental crises call for more CV research
Nov 18th, 2024
Aha24 Nejm Web Image
AHA24
Streamlining the pathway to publish cardiovascular research
Nov 18th, 2024
Casadei headshot
AHA24
Dissecting the complex relationship between atrial cardiomyopathy and stroke
Nov 18th, 2024
Stage shot
AHA24
LBS 04: Coronary and valvular heart disease
Nov 18th, 2024